Cardiovascular Pharmacology Laboratory
Campinas, São Paulo, 13083-888, Brazil
NCT Number: NCT01833429
The contribution of this study is the unedited evaluation of the circadian autonomic profiles of resistant hypertension with and without white-coat response.
Looking for future studies?
Notify Me30 year–60 year
All sexes
Observational
Campinas, São Paulo, 13083-888, Brazil
All patients were submitted to office blood pressure measurement, Ambulatory blood pressure monitoring and 24-hour Holter monitoring.
Baseline blood samples for the measurement of glycemia (mg/dL), total cholesterol (mg/dL), LDL cholesterol (mg/dL), triglycerides (mg/dL), creatinine (mg/dL), serum uric acid, serum sodium, serum potassium, plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were collected at 08:00 after overnight fasting.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 months
The autonomic nervous system can be assessed by the heart rate variability. Variations in heart rate variability are normally observed in association with diurnal rhythms and blood pressure changes. The heart rate variability parameters are different in many studies, although the consensus is that lower values of the indices of vagal as well as high indices of sympathetic functions are associated prospectively with death and disability.
In humans, the disturbances of the circadian rhythms of heart rate variability and blood pressure have been intensively studied, mainly due to the increased cardiovascular death reported during the morning hours
University of Campinas, Brazil
Other
Circadian Autonomic Disturbances in Resistant Hypertension With and Without White-coat Phenomenon
Acronym: RH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05395403
Cardiovascular Diseases, Hypertension
Birmingham, Alabama, United States
View Trial DetailsNCT02667912
Cardiovascular Diseases, Hypertension
Tomsk, Russia
View Trial DetailsNCT01520506
Cardiovascular Diseases, Chronic Disease
Antwerp, Belgium
View Trial DetailsNCT01570777
Cardiovascular Diseases, Essential Hypertension
Paris, France
View Trial Details